CSL Breaks Ground on Major Expansion of Plasma Therapy Facility in Illinois CSL is expanding its manufacturing facility in Illinois with a $1.5 billion investment, aiming to bolster production of crucial plasma-derived therapies and create 300 new jobs.

CSL Breaks Ground on Major Expansion of Plasma Therapy Facility in Illinois #United_States #CSL #Kankakee #plasma_therapy

Accord Plasma B.V. Enhances Global Plasma Therapy with Prothya Acquisition Accord Plasma B.V., part of Intas Pharmaceuticals, has acquired Prothya Biosolutions, boosting global access to plasma-derived therapies. This move strengthens their capabilities.

Accord Plasma B.V. Enhances Global Plasma Therapy with Prothya Acquisition #London #United_Kingdom #Accord_Healthcare #Prothya_Biosolutions #plasma_therapy

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Prothya Biosolutions Acquisition Accord Plasma B.V. has successfully acquired Prothya Biosolutions, enhancing its capacity in plasma therapy worldwide and meeting rising demands.

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Prothya Biosolutions Acquisition #London #United_Kingdom #Prothya_Biosolutions #Accord_Plasma #plasma_therapy

GC Biopharma and Thai Red Cross Unite for Innovative Plasma Therapy Collaboration GC Biopharma strengthens its collaboration with Thai Red Cross Society through a new MOU to enhance local production of plasma-derived therapies.

GC Biopharma and Thai Red Cross Unite for Innovative Plasma Therapy Collaboration #South_Korea #GC_Biopharma #Yongin #Thai_Red_Cross #plasma_therapy